EDIT · CIK 0001650664 · FY2025 live · 2025-12-31
Editas Medicine, Inc.
View as
Model
Classic Z
FY2025
−13.98
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
8.45
0–100 · Classic Z tape · not a PD
Book standing
6
Year change
—
Market PD
—
O-score
15
Events on this name
Same published rows as Today. Not a live recompute.
Market PD unavailable
watch · 41
−13.98
Z″ −29.91
Score −13.98 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.631.2 × = 0.76X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−8.731.4 × = −12.22X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.863.3 × = −2.83X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.170.6 × = 0.10X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.221 × = 0.22
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Editas Medicine, Inc. is on classic Z at −13.98 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 11th percentile in Healthcare.
- SNTIDistressSenti Biosciences Holdings, Inc.−13.94
- TLSIDistressTriSalus Life Sciences, Inc.−13.93
- BMEADistressBiomea Fusion, Inc.−13.87
- NXTCDistressNextCure, Inc.−13.78
- SKYEDistressSkye Bioscience, Inc.−13.77
- GOSSDistressGossamer Bio, Inc.−14.21
- ICCMDistressIceCure Medical Ltd.−13.69
- XAIRDistressBeyond Air, Inc.−14.39
KPI widgets
Current assets
$164M
Total assets
$187M
Current liabilities
$46M
Total liabilities
$159M
Working capital
$118M
Retained earnings
−$1.6B
EBIT
−$160M
Total sales
$41M
Book equity
$27M
Accession 0001650664-26-000017. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.